Retaglutide is a novel GLP-1 receptor agonist currently under study for the control of metabolic disorders. This drug works by stimulating the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone https://oisiygsj157980.59bloggers.com/39393896/trelaglutide-exploring-a-new-therapy-for-chronic-diseases